Zobrazeno 1 - 10
of 34
pro vyhledávání: '"J K, Marshall"'
Autor:
C Pray, N Narula, E C Wong, J K Marshall, S Rangarajan, S Islam, A Bahonar, K F Alhabib, A Kontsevaya, F Ariffin, H U Co, W Al Sharief, A Szuba, A Wielgosz, M L Diaz, R Yusuf, L Kruger, B Soman, Y Li, C Wang, L Yin, M Erkin, F Lanas, K Davletov, A Rosengren, P Lopez-Jaramillo, R Khatib, A Oguz, R Iqbal, K Yeates, Á Avezum, W Reinisch, P Moayyedi, S Yusuf
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:20-22
Background The pathogenesis of inflammatory bowel disease (IBD) which includes Crohn’s disease (CD) and ulcerative colitis (UC), is believed to involve activation of the intestinal immune system in response to the gut microbiome among genetically s
Autor:
A Neustaeter, J Shao, M Xue, C Antonio Hernández Rocha, S -H Lee, H Leibovitzh, K Madsen, J B Meddings, O Espin-Garcia, A M Griffiths, P Moayyedi, A H Steinhart, R Panancionne, H Huynh, K Jacobson, G Aumais, D Mack, C Bernstein, J K Marshall, W Xu, W Turpin, K Croitoru
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:67-68
Background Crohn’s disease (CD) is a chronic relapsing inflammatory disease of the gastrointestinal tract. The etiology of CD may arise from complex interactions including host genetics, diet, and the intestinal microbiome. Increased consumption of
Publikováno v:
Journal of Crohn's and Colitis. 17:i150-i151
Background Scoring indices used in clinical trials for moderate-severe ulcerative colitis (UC) may lack specificity as a prognostic tool. We developed and internally validated a prognostic scoring index for UC patients on therapy that considers basel
Autor:
A Neustaeter, S -H Lee, M Xue, H Leibovitzh, K Madsen, J B Meddings, O Espin-Garcia, A M Griffiths, P Moayyedi, A H Steinhart, R Panancionne, H Huynh, K Jacobson, G Aumais, D Mack, C Bernstein, J K Marshall, W Xu, W Turpin, K Croitoru
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:55-55
Background The incidence of Crohn’s disease (CD) is increasing globally, indicating a significant environmental influence such as diet. A plethora of dietary adherence (DA) patterns exist in the literature: the Mediterranean Diet (MD), Empirical Di
Autor:
H Leibovitzh, S H Lee, M Xue, J A Raygoza Garay, C Hernandez-Rocha, K L Madsen, J B Meddings, D S Guttman, O Espin-Garcia, M I Smith, A Goethel, P Moayyedi, A H Steinhart, R Panancionne, H Huynh, K Jacobson, G Aumais, D R Mack, M Abreu, C N Bernstein, J K Marshall, D Turner, W Xu, W Turpin, K Croitoru
Publikováno v:
Journal of Crohn's and Colitis. 16:i597-i598
Background The gut microbiome may play a role in gut barrier homeostasis including epithelial barrier integrity and function. However, data are scarce and limited to animal studies. We aimed to assess if alterations in the gut microbiome are associat
Publikováno v:
Journal of animal science. 90
Salmonella enterica Typhimurium (ST) is of concern in the swine industry with relevance for animal health and consumer safety. Nutritional strategies might help to reduce ST infection and transmission. This study examined the potential of wheat (Trit
Publikováno v:
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 24(6)
Current diagnostic criteria for functional gut disorder are based on symptom clusters observed after sporadic onset. It remains unclear whether symptoms group similarly in functional disorders of postinfectious etiology. We utilized observational dat
Autor:
S. Ziabakhsh, A. M. Perks, J. J. Dore, J. K. Marshall, T. Ruiz, E. Vanderhorst, B. A. Woods, J. Thom, R. Dyer
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 68:505-513
Lungs from fetal guinea pigs (54–67 days of gestation) were supported in vitro, and lung liquid secretion rates were measured by a dye-dilution technique. The average secretion rate in the first hour was 2.14 ± 0.08 (SE) mL∙kg−1 body weight∙
Publikováno v:
Alimentary pharmacologytherapeutics. 26(4)
Individual studies suggest that post-infectious irritable bowel syndrome is common, but symptoms gradually improve.To review evidence for an association between intestinal infection and development of irritable bowel syndrome, assess the prognosis of
Autor:
J K, Marshall
Publikováno v:
IDrugs : the investigational drugs journal. 2(10)
Schering-Plough's interleukin (IL)-10 (ilodecakin) is under investigation for the potential treatment of autoimmune diseases, solid tumors, ulcerative colitis, Crohn's disease and organ transplantation. In June 1996, ilodecakin entered phase II trial